Perspective Therapeutics (CATX) Retained Earnings (2016 - 2026)
Perspective Therapeutics' Retained Earnings history spans 16 years, with the latest figure at -$361.0 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 44.47% to -$361.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$361.0 million, a 44.47% decrease, with the full-year FY2025 number at -$334.8 million, down 656449.02% from a year prior.
- Retained Earnings hit -$361.0 million in Q1 2026 for Perspective Therapeutics, down from -$334.8 million in the prior quarter.
- Over the last five years, Retained Earnings for CATX hit a ceiling of -$51000.0 in Q4 2024 and a floor of -$361.0 million in Q1 2026.
- Historically, Retained Earnings has averaged -$173.8 million across 5 years, with a median of -$152.4 million in 2023.
- Biggest five-year swings in Retained Earnings: surged 99.97% in 2024 and later tumbled 656449.02% in 2025.
- Tracing CATX's Retained Earnings over 5 years: stood at -$105.9 million in 2022, then tumbled by 43.9% to -$152.4 million in 2023, then surged by 99.97% to -$51000.0 in 2024, then tumbled by 656449.02% to -$334.8 million in 2025, then decreased by 7.82% to -$361.0 million in 2026.
- Business Quant data shows Retained Earnings for CATX at -$361.0 million in Q1 2026, -$334.8 million in Q4 2025, and -$297.3 million in Q3 2025.